BioPharma Credit Valuation
Is B3P undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of B3P when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: B3P (€0.79) is trading below our estimate of fair value (€1.37)
Significantly Below Fair Value: B3P is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for B3P?
Key metric: As B3P is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is B3P's PE Ratio? | |
|---|---|
| PE Ratio | 9.4x |
| Earnings | US$109.36m |
| Market Cap | US$1.03b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.3x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does B3P's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 13.3x | ||
MLP MLP | 9.9x | 7.8% | €649.2m |
AR4 AURELIUS Equity Opportunities SE KGaA | 3.8x | n/a | €389.6m |
O4B OVB Holding | 15.2x | 3.5% | €279.3m |
DBAN Deutsche Beteiligungs | 24.4x | 54.1% | €428.9m |
B3P BioPharma Credit | 9.4x | n/a | €1.0b |
Price-To-Earnings vs Peers: B3P is good value based on its Price-To-Earnings Ratio (9.4x) compared to the peer average (13.5x).
Price to Earnings Ratio vs Industry
How does B3P's PE Ratio compare vs other companies in the DE Capital Markets Industry?
| 4 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
AR4 AURELIUS Equity Opportunities SE KGaA | 3.8x | n/a | US$412.19m |
HXCK Ernst Russ | 3.7x | -18.2% | US$208.47m |
VG8 Varengold Bank | 2x | n/a | US$26.85m |
XE8 Black Sea Property | 0.7x | n/a | US$7.80m |
| 4 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: B3P is good value based on its Price-To-Earnings Ratio (9.4x) compared to the German Capital Markets industry average (20.7x).
Price to Earnings Ratio vs Fair Ratio
What is B3P's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 9.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate B3P's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Yeahka
HK$4.5b
An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.
4YE
HK$1.25
7D
-11.3%
1Y
-29.0%
Exor
€20.3b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
EYX
€92.90
7D
-2.4%
1Y
7.2%
Merchants Bancorp
US$1.8b
Operates as the diversified bank holding company in the United States.
3KD
US$37.00
7D
-3.1%
1Y
21.7%